C

Compass Therapeutics Inc.
NASDAQ:CMPX

Watchlist Manager
Compass Therapeutics Inc.
NASDAQ:CMPX
Watchlist
Price: 3.33 USD 8.47% Market Closed
Market Cap: 460.5m USD

Intrinsic Value

The intrinsic value of one CMPX stock under the Base Case scenario is 5.43 USD. Compared to the current market price of 3.33 USD, Compass Therapeutics Inc. is Undervalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CMPX Intrinsic Value
5.43 USD
Undervaluation 39%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Compass Therapeutics Inc.

What is Valuation History?
Compare CMPX to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CMPX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Compass Therapeutics Inc.
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Compass Therapeutics Inc.

Current Assets 132.8m
Cash & Short-Term Investments 126.7m
Other Current Assets 6m
Non-Current Assets 7.7m
PP&E 7.1m
Other Non-Current Assets 568k
Efficiency

Free Cash Flow Analysis
Compass Therapeutics Inc.

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Compass Therapeutics Inc.

Revenue
850k USD
Operating Expenses
-57.5m USD
Operating Income
-56.6m USD
Other Expenses
7.3m USD
Net Income
-49.4m USD
Fundamental Scores

CMPX Profitability Score
Profitability Due Diligence

Compass Therapeutics Inc.'s profitability score is 16/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Low Gross Margin
Negative 3Y Average Net Margin
16/100
Profitability
Score

Compass Therapeutics Inc.'s profitability score is 16/100. The higher the profitability score, the more profitable the company is.

CMPX Solvency Score
Solvency Due Diligence

Compass Therapeutics Inc.'s solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
72/100
Solvency
Score

Compass Therapeutics Inc.'s solvency score is 72/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CMPX Price Targets Summary
Compass Therapeutics Inc.

Wall Street analysts forecast CMPX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CMPX is 13.06 USD with a low forecast of 6.06 USD and a high forecast of 33.6 USD.

Lowest
Price Target
6.06 USD
82% Upside
Average
Price Target
13.06 USD
292% Upside
Highest
Price Target
33.6 USD
909% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Compass Therapeutics Inc.
does not pay dividends
Shareholder Yield

Current shareholder yield for CMPX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CMPX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CMPX stock?

The intrinsic value of one CMPX stock under the Base Case scenario is 5.43 USD.

Is CMPX stock undervalued or overvalued?

Compared to the current market price of 3.33 USD, Compass Therapeutics Inc. is Undervalued by 39%.

Back to Top